Harbour BioMed

1 Follower


Harbour BioMed is an Immune-Driven Global Bio-therapeutics Company discovering, developing and delivering Innovative Therapeutics for Oncology and Immunology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery - the H2L2 and the HCAb.


Add photos to showcase Harbour BioMed’s culture


Add Harbour BioMed’s values

Insider experiences

Share your experience of working at Harbour BioMed

Jingsong Wang
Founder, Chairman & Chief Executive Officer
Mai-Jing Liao
Chief Commercial Officer
Lile Liu
SVP & Head of Technology Platform
Yiping Rong
SVP, Head of Discovery
Weihao Xu
Chief Strategy Officer
Humphrey Gardner
Chief Medical Officer

Add your teams to show how people work together at Harbour BioMed

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure